Page last updated: 2024-08-21

nitrofen and ER-Negative PR-Negative HER2-Negative Breast Cancer

nitrofen has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Agopsowicz, K; Garcia, E; Hitt, MM; Jay, DA; Luna, I; Persad, KL; Persad, S; West, FG	1

Other Studies

1 other study(ies) available for nitrofen and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transition. Scientific reports, 2021, 06-03, Volume: 11, Issue:1 Topics: Animals; Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Drug Discovery; Epithelial-Mesenchymal Transition; Female; Humans; Mice; Molecular Structure; Neoplasm Invasiveness; Phenyl Ethers; Rats; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2021

Article

Year

Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transition.

Scientific reports, 2021, 06-03, Volume: 11, Issue:1

Topics: Animals; Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Drug Discovery; Epithelial-Mesenchymal Transition; Female; Humans; Mice; Molecular Structure; Neoplasm Invasiveness; Phenyl Ethers; Rats; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2021